SINO MEDICAL SCIENCES TECHNOLOGY INC. Financials Sino Medical Sciences Technology Inc.
Equities
688108
CNE100003NY2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.25 CNY | +2.65% |
|
+12.95% | -10.36% |
| Feb. 27 | Sino Medical Sciences Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 01 | Sino Medical Sciences Technology's Unit Gets Certificate for Catheter | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 6,667 | 5,523 | 3,366 | 2,341 | 5,146 |
| Enterprise Value (EV) 1 | 6,020 | 4,961 | 3,123 | 2,196 | 5,101 |
| P/E ratio | 67.8 x | 269 x | -25.7 x | -14.3 x | -126 x |
| Yield | 0.62% | - | - | - | - |
| Capitalization / Revenue | 15.3 x | 16.9 x | 17.3 x | 12.1 x | 15 x |
| EV / Revenue | 13.8 x | 15.2 x | 16.1 x | 11.4 x | 14.9 x |
| EV / EBITDA | 47.5 x | 107 x | -27.2 x | -12.6 x | -739 x |
| EV / FCF | -64 x | -101 x | -19.2 x | -13.5 x | -211 x |
| FCF Yield | -1.56% | -0.99% | -5.22% | -7.41% | -0.47% |
| Price to Book | 6.07 x | 5.12 x | 3.63 x | 2.76 x | 6.28 x |
| Nbr of stocks (in thousands) | 410,000 | 410,000 | 410,000 | 410,000 | 410,000 |
| Reference price 2 | 16.26 | 13.47 | 8.210 | 5.710 | 12.55 |
| Announcement Date | 4/23/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 380.4 | 435.9 | 327.4 | 194.4 | 192.9 | 343.3 |
| EBITDA 1 | 119 | 126.8 | 46.19 | -114.9 | -174.8 | -6.902 |
| EBIT 1 | 98.94 | 100.1 | 9.559 | -164.9 | -222.4 | -57.82 |
| Operating Margin | 26.01% | 22.96% | 2.92% | -84.85% | -115.34% | -16.84% |
| Earnings before Tax (EBT) 1 | 102.7 | 108 | 28.84 | -163.1 | -221.3 | -67.86 |
| Net income 1 | 89.19 | 90.04 | 22.49 | -130.8 | -162.4 | -39.63 |
| Net margin | 23.45% | 20.65% | 6.87% | -67.28% | -84.2% | -11.55% |
| EPS 2 | 0.2500 | 0.2400 | 0.0500 | -0.3200 | -0.4000 | -0.1000 |
| Free Cash Flow 1 | -25.94 | -94.02 | -49.18 | -162.9 | -162.6 | -24.21 |
| FCF margin | -6.82% | -21.57% | -15.02% | -83.79% | -84.32% | -7.05% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | 0.1000 | - | - | - | - |
| Announcement Date | 10/9/19 | 4/23/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 382 | 647 | 561 | 243 | 145 | 44.1 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -25.9 | -94 | -49.2 | -163 | -163 | -24.2 |
| ROE (net income / shareholders' equity) | 13.6% | 10% | 2.07% | -13% | -18.9% | -4.96% |
| ROA (Net income/ Total Assets) | 8.16% | 6.22% | 0.49% | -8.88% | -12.8% | -3.21% |
| Assets 1 | 1,094 | 1,448 | 4,562 | 1,472 | 1,268 | 1,236 |
| Book Value Per Share 2 | 1.950 | 2.680 | 2.630 | 2.260 | 2.070 | 2.000 |
| Cash Flow per Share 2 | 1.040 | 1.560 | 1.330 | 0.7000 | 0.5000 | 0.4600 |
| Capex 1 | 98.9 | 180 | 113 | 158 | 111 | 67.7 |
| Capex / Sales | 25.99% | 41.3% | 34.45% | 81.53% | 57.43% | 19.71% |
| Announcement Date | 10/9/19 | 4/23/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/23/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.36% | 637M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 688108 Stock
- Financials Sino Medical Sciences Technology Inc.
